Cargando…
A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India
BACKGROUND: The unprecedented first wave of the COVID-19 pandemic severely impacted mental health services globally. However, the negative impact of such disruptions on people with substance use disorders (SUD) seeking treatment remains unclear. We aim to explore the behaviors adopted by these indiv...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992763/ https://www.ncbi.nlm.nih.gov/pubmed/35400749 http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_557_21 |
_version_ | 1784683795233898496 |
---|---|
author | Arya, Sidharth Ghosh, Abhishek Mishra, Shree Swami, Mukesh Kumar Prasad, Sambhu Somani, Aditya Basu, Aniruddha Sharma, Kshitiz Padhy, Susanta Kumar Nebhinani, Naresh Singh, Lokesh Kumar Choudhury, Shinjini Basu, Debasish Gupta, Rajiv |
author_facet | Arya, Sidharth Ghosh, Abhishek Mishra, Shree Swami, Mukesh Kumar Prasad, Sambhu Somani, Aditya Basu, Aniruddha Sharma, Kshitiz Padhy, Susanta Kumar Nebhinani, Naresh Singh, Lokesh Kumar Choudhury, Shinjini Basu, Debasish Gupta, Rajiv |
author_sort | Arya, Sidharth |
collection | PubMed |
description | BACKGROUND: The unprecedented first wave of the COVID-19 pandemic severely impacted mental health services globally. However, the negative impact of such disruptions on people with substance use disorders (SUD) seeking treatment remains unclear. We aim to explore the behaviors adopted by these individuals to overcome the service disruptions. MATERIALS AND METHODS: We explored the changes related to substance use behavior (quit attempts, withdrawal experienced, treatment-seeking, and risky behaviors), and behavioral changes in response to COVID-19 lockdown. A cross-sectional survey was conducted among 404 people with SUD seeking treatment from seven centers across India. They were assessed by a specially designed structured questionnaire during the first wave (June–September) of the pandemic. RESULTS: An overwhelming majority experienced withdrawal symptoms, with close to half making quit attempts and seeking treatment during the lockdown. Three-fourth of the sample reported difficulty in accessing treatment services and medications. Patients with opioid use were significantly more likely to think about quitting (χ(2) = 20.408, P = 0.000), make attempts (χ(2) = 12.436, P = 0.000), seek treatment (χ(2) = 7.536, P = 0.006), and self-medicate for withdrawal symptoms (χ(2) = 5.885, P = 0.015). In turn, those with alcohol use were more likely to use telepsychiatry services (χ(2) = 35.143, P = 0.000) and experience stigma by family members (χ(2) = 29.951, P = 0.000) and neighbors (χ(2) = 17.725, P = 0.000). Among COVID-19 safety precautions, majority practised wearing masks and social distancing but not others. CONCLUSION: COVID-19 lockdown led a significant proportion of substance users, especially opioid users, to make quit attempts and seek help. However, these could not be sustained due to difficulty in accessing treatment services. Further, significant proportion failed to adhere to COVID-19 safety precautions. |
format | Online Article Text |
id | pubmed-8992763 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-89927632022-04-09 A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India Arya, Sidharth Ghosh, Abhishek Mishra, Shree Swami, Mukesh Kumar Prasad, Sambhu Somani, Aditya Basu, Aniruddha Sharma, Kshitiz Padhy, Susanta Kumar Nebhinani, Naresh Singh, Lokesh Kumar Choudhury, Shinjini Basu, Debasish Gupta, Rajiv Indian J Psychiatry Original Article BACKGROUND: The unprecedented first wave of the COVID-19 pandemic severely impacted mental health services globally. However, the negative impact of such disruptions on people with substance use disorders (SUD) seeking treatment remains unclear. We aim to explore the behaviors adopted by these individuals to overcome the service disruptions. MATERIALS AND METHODS: We explored the changes related to substance use behavior (quit attempts, withdrawal experienced, treatment-seeking, and risky behaviors), and behavioral changes in response to COVID-19 lockdown. A cross-sectional survey was conducted among 404 people with SUD seeking treatment from seven centers across India. They were assessed by a specially designed structured questionnaire during the first wave (June–September) of the pandemic. RESULTS: An overwhelming majority experienced withdrawal symptoms, with close to half making quit attempts and seeking treatment during the lockdown. Three-fourth of the sample reported difficulty in accessing treatment services and medications. Patients with opioid use were significantly more likely to think about quitting (χ(2) = 20.408, P = 0.000), make attempts (χ(2) = 12.436, P = 0.000), seek treatment (χ(2) = 7.536, P = 0.006), and self-medicate for withdrawal symptoms (χ(2) = 5.885, P = 0.015). In turn, those with alcohol use were more likely to use telepsychiatry services (χ(2) = 35.143, P = 0.000) and experience stigma by family members (χ(2) = 29.951, P = 0.000) and neighbors (χ(2) = 17.725, P = 0.000). Among COVID-19 safety precautions, majority practised wearing masks and social distancing but not others. CONCLUSION: COVID-19 lockdown led a significant proportion of substance users, especially opioid users, to make quit attempts and seek help. However, these could not be sustained due to difficulty in accessing treatment services. Further, significant proportion failed to adhere to COVID-19 safety precautions. Wolters Kluwer - Medknow 2022 2022-01-21 /pmc/articles/PMC8992763/ /pubmed/35400749 http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_557_21 Text en Copyright: © 2022 Indian Journal of Psychiatry https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Arya, Sidharth Ghosh, Abhishek Mishra, Shree Swami, Mukesh Kumar Prasad, Sambhu Somani, Aditya Basu, Aniruddha Sharma, Kshitiz Padhy, Susanta Kumar Nebhinani, Naresh Singh, Lokesh Kumar Choudhury, Shinjini Basu, Debasish Gupta, Rajiv A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India |
title | A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India |
title_full | A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India |
title_fullStr | A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India |
title_full_unstemmed | A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India |
title_short | A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India |
title_sort | multicentric survey among patients with substance use disorders during the covid-19 lockdown in india |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992763/ https://www.ncbi.nlm.nih.gov/pubmed/35400749 http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_557_21 |
work_keys_str_mv | AT aryasidharth amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT ghoshabhishek amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT mishrashree amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT swamimukeshkumar amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT prasadsambhu amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT somaniaditya amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT basuaniruddha amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT sharmakshitiz amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT padhysusantakumar amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT nebhinaninaresh amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT singhlokeshkumar amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT choudhuryshinjini amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT basudebasish amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT guptarajiv amulticentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT aryasidharth multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT ghoshabhishek multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT mishrashree multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT swamimukeshkumar multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT prasadsambhu multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT somaniaditya multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT basuaniruddha multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT sharmakshitiz multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT padhysusantakumar multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT nebhinaninaresh multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT singhlokeshkumar multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT choudhuryshinjini multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT basudebasish multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia AT guptarajiv multicentricsurveyamongpatientswithsubstanceusedisordersduringthecovid19lockdowninindia |